Blood pressure drugs may offer benefits in valvular heart disease

Drugs used to treat blood pressure could offer significant benefits to patients with one of the most common forms of valvular heart disease, new research at the University of Dundee and NHS Tayside has revealed.

Aortic stenosis - when the main valve between the heart and the rest of the body becomes narrowed - is one of the most common forms of valvular in the developed world, affecting around 5 % of the population and growing.

Patients with aortic stenosis are often asymptomatic. However, when the valve becomes too tight they often experience chest pain and when they are physically active.

The mainstay of treatment is surgery to replace the valve. For patients who have no symptoms it had not been known whether offering other treatments such as drugs called or angiotensin blockers, commonly used to treat blood pressure, may offer benefit, or indeed may delay the need for an operation.

Chim Lang, Professor of at the University of Dundee, and his team studied the records of Tayside patients with aortic stenosis who have undergone heart scans over the last 20 years in Tayside.

'From looking at these records, we have shown that patients taking drugs that block the renin angiotensin system like ACE Inhibitors and angiotensin blockers had significantly lower rates of all-cause death and ,' said Professor Lang.

'Aortic stenosis is a growing problem. Physicians have previously not known whether to continue these ACE Inhibitor medications or not. On the one hand, a fall in blood pressure may not be helpful but on the other hand these drugs offer many protective benefits.

'We observed that patients with who were taking these medications had a better outcome. This observation, however, needs to be confirmed by prospective clinical trials.'

Details of the research are published in the Journal of the American College of Cardiology.

Provided by University of Dundee

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Major discovery in the treatment of aortic valve stenosis

Apr 18, 2008

A team of scientists from the Université de Montréal and the Montreal Heart Institute Research Centre, led by Dr. Jean-Claude Tardif, has completed an important study that show how a new type of medication can lead to an ...

Inflammation behind heart valve disease

Mar 15, 2011

Research from Karolinska Institutet in Sweden shows, that a specific inflammatory factor may be important in the development of the heart valve disease aortic stenosis. The results suggest that anti-inflammatory medication ...

'Healthy' sterols may pose health risk

Jul 14, 2008

Plant sterols have been touted as an effective way to lower cholesterol and reduce the risk of heart disease. However, a research study in the July JLR has uncovered that these compounds do have their own risks, as they can ...

Recommended for you

Growing a blood vessel in a week

9 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

12 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments